NCT02952131View on ClinicalTrials.gov

Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells in Inflammatory Bowel Disease

PHASE1/PHASE2SuspendedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2026

Conditions
Inflammatory Bowel Diseases
Interventions
PROCEDURE

Lipoaspiration

Closed Syringe Harvesting Autologous Subdermal Fat

PROCEDURE

AD-cSVF

Use of Centricyte 1000 to isolate adipose stem/stromal cells via centrifugation

PROCEDURE

Normal Saline IV

Normal Saline IV containing AD-cSVF

Trial Locations (1)

59870

Regenevita LLC, Stevensville

Sponsors
All Listed Sponsors
collaborator

Terry, Glenn C., M.D.

INDIV

lead

Healeon Medical Inc

INDUSTRY